US Stock MarketDetailed Quotes

SBC SBC Medical Group

Watchlist
  • 6.040
  • -0.260-4.13%
Close Dec 20 16:00 ET
  • 6.040
  • 0.0000.00%
Post 20:01 ET
622.25MMarket Cap75.50P/E (TTM)

SBC Medical Group Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
107,012.84%50.64M
27.89M
-47.37K
Net income from continuing operations
594.48%38.56M
--14.23M
--5.55M
Operating gains losses
75.15%-472.7K
--0
---1.9M
Depreciation and amortization
106.45%12.25M
--2.56M
--5.93M
Deferred tax
205.46%4.11M
--5.49M
---3.9M
Other non cash items
-3.05%3.3M
--873.6K
--3.4M
Change In working capital
27.49%-7.68M
--4.65M
---10.59M
-Change in receivables
37.41%-6.01M
---2.35M
---9.6M
-Change in inventory
-173.90%-1.83M
--2.21M
---666.64K
-Change in prepaid assets
109.27%536.75K
---5.64M
---5.79M
-Change in payables and accrued expense
-53.85%7.91M
--6.46M
--17.13M
-Change in other current assets
87.52%-1.33M
--555.67K
---10.64M
-Change in other current liabilities
9.83%-3.15M
---897.96K
---3.5M
-Change in other working capital
-253.58%-3.8M
--4.31M
--2.48M
Cash from discontinued investing activities
Operating cash flow
107,012.84%50.64M
--27.89M
---47.37K
Investing cash flow
Cash flow from continuing investing activities
105.58%1.82M
-6.84M
-32.65M
Net PPE purchase and sale
93.49%-1.48M
---6.81M
---22.71M
Net intangibles purchase and sale
---1.68M
--0
--0
Net business purchase and sale
111.14%722.55K
--0
---6.49M
Net investment purchase and sale
176.37%2.02M
--28.23K
---2.65M
Net other investing changes
376.75%2.24M
---58.49K
---809.12K
Cash from discontinued investing activities
Investing cash flow
105.58%1.82M
---6.84M
---32.65M
Financing cash flow
Cash flow from continuing financing activities
176.91%6.14M
-127.22K
-7.98M
Net issuance payments of debt
170.40%3.58M
---39.48K
---5.08M
Net common stock issuance
--10
--0
--0
Net other financing activities
188.34%2.56M
---87.74K
---2.89M
Cash from discontinued financing activities
Financing cash flow
176.91%6.14M
---127.22K
---7.98M
Net cash flow
Beginning cash position
-50.49%51.74M
--77.43M
--104.5M
Current changes in cash
244.07%58.6M
--20.92M
---40.68M
Effect of exchange rate changes
39.50%-7.31M
--4.67M
---12.09M
End cash Position
99.12%103.02M
--103.02M
--51.74M
Free cash flow
257.79%39.44M
--21.08M
---24.99M
Currency Unit
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2023(Q4)Dec 31, 2023(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 107,012.84%50.64M27.89M-47.37K
Net income from continuing operations 594.48%38.56M--14.23M--5.55M
Operating gains losses 75.15%-472.7K--0---1.9M
Depreciation and amortization 106.45%12.25M--2.56M--5.93M
Deferred tax 205.46%4.11M--5.49M---3.9M
Other non cash items -3.05%3.3M--873.6K--3.4M
Change In working capital 27.49%-7.68M--4.65M---10.59M
-Change in receivables 37.41%-6.01M---2.35M---9.6M
-Change in inventory -173.90%-1.83M--2.21M---666.64K
-Change in prepaid assets 109.27%536.75K---5.64M---5.79M
-Change in payables and accrued expense -53.85%7.91M--6.46M--17.13M
-Change in other current assets 87.52%-1.33M--555.67K---10.64M
-Change in other current liabilities 9.83%-3.15M---897.96K---3.5M
-Change in other working capital -253.58%-3.8M--4.31M--2.48M
Cash from discontinued investing activities
Operating cash flow 107,012.84%50.64M--27.89M---47.37K
Investing cash flow
Cash flow from continuing investing activities 105.58%1.82M-6.84M-32.65M
Net PPE purchase and sale 93.49%-1.48M---6.81M---22.71M
Net intangibles purchase and sale ---1.68M--0--0
Net business purchase and sale 111.14%722.55K--0---6.49M
Net investment purchase and sale 176.37%2.02M--28.23K---2.65M
Net other investing changes 376.75%2.24M---58.49K---809.12K
Cash from discontinued investing activities
Investing cash flow 105.58%1.82M---6.84M---32.65M
Financing cash flow
Cash flow from continuing financing activities 176.91%6.14M-127.22K-7.98M
Net issuance payments of debt 170.40%3.58M---39.48K---5.08M
Net common stock issuance --10--0--0
Net other financing activities 188.34%2.56M---87.74K---2.89M
Cash from discontinued financing activities
Financing cash flow 176.91%6.14M---127.22K---7.98M
Net cash flow
Beginning cash position -50.49%51.74M--77.43M--104.5M
Current changes in cash 244.07%58.6M--20.92M---40.68M
Effect of exchange rate changes 39.50%-7.31M--4.67M---12.09M
End cash Position 99.12%103.02M--103.02M--51.74M
Free cash flow 257.79%39.44M--21.08M---24.99M
Currency Unit USDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAP
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.